Brainstorm Cell Therapeutics shares owned by Weaver Consulting Group
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Weaver Consulting Group
from 13F filings
Historical chart of Weaver Consulting Group investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Weaver Consulting Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Weaver Consulting Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $54k | 234k | 0.23 |
| 2024-06-30 | $79k | 234k | 0.34 |
| 2024-03-31 | $113k | 199k | 0.56 |
| 2023-12-31 | $11k | 209k | 0.05 |
| 2023-09-30 | $14k | 144k | 0.10 |
| 2023-06-30 | $54k | 116k | 0.47 |
| 2023-03-31 | $75k | 94k | 0.80 |
| 2022-12-31 | $6.0k | 119k | 0.05 |
| 2022-09-30 | $47k | 164k | 0.29 |
| 2022-06-30 | $289k | 105k | 2.76 |
| 2022-03-31 | $437k | 130k | 3.36 |
| 2021-12-31 | $622k | 156k | 4.00 |
| 2021-09-30 | $170k | 52k | 3.30 |
| 2021-06-30 | $186k | 49k | 3.81 |
| 2021-03-31 | $192k | 50k | 3.84 |